• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Canadian journal of hospital pharmacy. >Cost Impact of Using Patients' Own Multiclose Medications in Hospital
【24h】

Cost Impact of Using Patients' Own Multiclose Medications in Hospital

机译：在医院使用患者自己的多药治疗的费用影响

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: The use of patients' own medications may allow minimization of drug wastage and costs. However, the cost impact of this practice, taking into account the time that pharmacy personnel spend on verification, is unknown.Objectives: To determine the cost impact of using patients' own multidose medications within a surgical population, relative to the cost of routine dispensing; to describe the prescribing of multidose medications with regard to type, prevalence, quantity, and formulary status; and to determine the percentage of medications suitable for use after verification.Methods: In this prospective, consecutive, time-and-motion case series, admission orders for patients newly admitted to 6 surgical units were screened to identify patients' own multidose medications that required verification. The total time required for all verification-related activities was captured. Data were collected over 3 weeks in early 2011.Results: Of the 250 patients admitted, 51 (20.4%) had a prescription for one of their own multidose medications. Verification was completed for 67 (79%) of 85 prescribed items, of which 61 (91%) were deemed suitable for use. Thirty-five different medication types were identified. Of the 85 prescribed medications, 57 (67%) were on formulary. The most common routes of administration for these 85 prescribed items were inhalation (56 [66%]), nasal (9 [11%]), and ophthalmic (8 [9%]). The average cost ± standard deviation was $24.54 ± $32.33 per multidose item. The average time required for verification was 10.5 ± 6.7 min per patient (4.8 ± 3.3 min per medication). The cost impact was calculated as the difference between the drug cost with routine hospital dispensing and the cost of verifying home medications, where a positive value indicated a lower cost with verification of home medications (i.e., a saving for the hospital). The average cost impact was $40.05 ± $42.60 per patient (p < 0.001 by 1-sample t test) ($18.85 ± $15.42 per medication). A total cost saving of $1601.85 was realized.Conclusions: Using patients' own multidose medications instead of routine dispensing resulted in a cost saving of 74%, including labour costs for verification by the pharmacist.
机译：背景：使用患者自己的药物可以最大程度地减少药物浪费和费用。然而，考虑到药房人员花费在验证上的时间，这种做法的成本影响尚不清楚。目的：确定相对于常规配药成本而言，在手术人群中使用患者自己的多剂量药物的成本影响;描述有关类型，患病率，数量和处方状态的多剂量药物处方;方法：在此前瞻性，连续，时空变化的病例系列中，筛选了新入院的6个外科病房的患者的入院医嘱，以确定患者自己需要的多剂量药物验证。记录了所有与验证相关的活动所需的总时间。在2011年初的3周内收集了数据。结果：在入院的250例患者中，有51例（20.4％）拥有自己的多剂量药物处方。 85个处方物品中的67个（79％）已完成验证，其中61个（91％）被认为适合使用。确定了35种不同的药物类型。在85种处方药中，有57种（67％）采用处方药。这85种处方药最常用的给药途径是吸入（56 [66％]），鼻腔（9 [11％]）和眼科（8 [9％]）。每个多剂量项目的平均成本±标准差为$ 24.54±$ 32.33。验证所需的平均时间为每位患者10.5±6.7分钟（每种药物为4.8±3.3分钟）。成本影响计算为常规医院配药的药品成本与验证家庭用药成本之间的差额，其中正值表示验证家庭用药成本较低（即，为医院节省了费用）。每位患者的平均成本影响为$ 40.05±$ 42.60（通过1样本t检验，p <0.001）（每种药物$ 18.85±$ 15.42）。总共节省了1601.85美元。结论：使用患者自己的多剂量药物代替常规配药可以节省74％的成本，其中包括由药剂师进行验证的人工成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号